AI assistant
Sending…
RESMED INC — Director's Dealing 2017
Jan 19, 2017
30071_dirs_2017-01-19_84864fbb-6023-4532-bcc4-b35eb4aa3fb6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2017-01-17
Reporting Person: Hollingshead James (President, Americas)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-01-17 | ResMed Common Stock | M | 5264 | $43.63 | Acquired | 46754 | Direct |
| 2017-01-17 | ResMed Common Stock | S | 5264 | $64.44 | Disposed | 41490 | Direct |
| 2017-01-17 | ResMed Common Stock | S | 1820 | $64.44 | Disposed | 39670 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-01-17 | ResMed Common Stock Options | $43.63 | M | 5264 | Disposed | 2020-03-01 | ResMed Common Stock (5264) | Direct |
Footnotes
F1: The transaction was conducted under a Rule 10b5-1 Plan.
F2: Represents date options first became exercisable. Options vest ? per year.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29